Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 1 |
Descriptor
| Anxiety | 1 |
| Autism Spectrum Disorders | 1 |
| Biochemistry | 1 |
| Children | 1 |
| Drug Use | 1 |
| Effect Size | 1 |
| Fear | 1 |
| Intelligence Tests | 1 |
| Interpersonal Competence | 1 |
| Nonverbal Communication | 1 |
| Outcomes of Treatment | 1 |
| More ▼ | |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
| Peabody Picture Vocabulary… | 1 |
What Works Clearinghouse Rating
Peer reviewed
Direct linkNadja Rita Ging-Jehli; Deepa Manda; Jill Hollway; Elizabeth Hurt; Stacey Moone; L. Eugene Arnold – Journal of Developmental and Physical Disabilities, 2021
This pilot placebo-controlled trial (NCT00965068, 07/28/2009) explored effects of cholesterol supplementation on autism spectrum disorder (ASD) symptoms in children with abnormally low cholesterol. Fifteen children age 4-12 with ASD and cholesterol <5th percentile for age/sex were randomized to 225 mg cholesterol vs. matched placebo twice daily…
Descriptors: Pilot Projects, Biochemistry, Rating Scales, Autism Spectrum Disorders
